NCI | Technology Transfer

METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

Read more about METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

Italy
15746399.3
Filed on 2015-02-04

METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

Read more about METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

France
15746399.3
Filed on 2015-02-04

METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

Read more about METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

Finland
15746399.3
Filed on 2015-02-04

METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

Read more about METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF

Spain
15746399.3
Filed on 2015-02-04

Recurrence Gene Signature Across Multiple Cancer Types

Read more about Recurrence Gene Signature Across Multiple Cancer Types

US Application 19/077,957
Filed on 2025-03-12

T CELL RECEPTORS RECOGNIZING MUTATED P53

Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53

Costa Rica
2025-0153
Filed on 2025-04-24

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Japan
2025-071352
Filed on 2025-04-23

PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

Read more about PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

European Patent
23820358.2
Filed on 2025-01-07

PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

Read more about PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

Israel
317206
Filed on 2024-11-24

NATURAL KILLER CELLS EXPRESSING A MESOTHELIN-TARGETED CHIMERIC ANTIGEN
RECEPTOR AND INTERLEUKIN-15 FOR THE TREATMENT OF SOLID TUMORS

Read more about NATURAL KILLER CELLS EXPRESSING A MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTOR AND INTERLEUKIN-15 FOR THE TREATMENT OF SOLID TUMORS

Patent Cooperation Treaty
PCT/US2025/029169
Filed on 2025-05-13

Subscribe to NCI